Skip to main content
Premium Trial:

Request an Annual Quote

N. American Research Parks Poised for 'Phenomenal Increase' in Life Science Jobs, Survey Finds

NEW YORK (GenomeWeb News) - North American technology research parks employ fewer life science jobs than other disciplines, but that is expected to change over the next few years as some cities develop new biomedical campuses or expand existing ones, according to a recent survey of tech park owners.
Walter Plosila, vice president in the Technology Partnership Practice of the Battelle Memorial Institute, which conducted the survey, told GenomeWeb Daily News sister publication BioRegion News that there will soon be more life science jobs at research parks because a greater number of new parks are focusing on nurturing startup biopharma and medical-device businesses.
Another reason is an emerging trend among tech parks to specialize in one or a few related technologies, he said.
According to the survey, released two weeks ago, 13.5 percent, or 35,734 jobs at North American research parks, were in software, while 11 percent, or 28,969 jobs, were in “computers and related hardware.” By comparison, 10.6 percent, or 28,007 jobs, were in the “drugs/pharmaceuticals/diagnostics” category, the survey said.
“I think that’s going to change,” Plosila said. “We’re seeing a phenomenal increase in biomedical parks, but they’re slowly coming online. … We’re seeing lots of these in the development stage around the country. They’re in development. As that happens, you’re going to see much more of the composition being in the biosciences broadly defined to include [agricultural biotech], medical devices, drugs and pharmaceuticals, and research and testing.”
Plosila spoke with BioRegion News after addressing a conference organized by the Association of University Research Parks, which with the nonprofit Battelle surveyed 134 owners and managers of 174 research parks registered in the US and Canada.

The complete version of this article appeared in last week’s issue of BioRegion News, a GenomeWeb Daily News sister publication.

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.